The United States Generic Drug Market reached a value of US$ 127.8 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 10.3% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Sie sind vermutlich noch nicht im Forum angemeldet - Klicken Sie hier um sich kostenlos anzumelden